Pure Global

IgE Rapid Quantitative Test - India CDSCO Medical Device Registration

IgE Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_a3491dfbfbd322084d68205a818b5c44_c384f6f46d1db0724c4ec097714551b9. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
IgE Rapid Quantitative Test
UID: IMP/IVD/2022/000074_a3491dfbfbd322084d68205a818b5c44_c384f6f46d1db0724c4ec097714551b9

Brand Name

Glycated Hemoglobin

Device Class

Class B

Approving Authority

CDSCO

Product Information

The IgE Rapid Quantitative Test along with Aehealth FIA Meter is intended for vitro quantitative determination of Immunoglobulin E๏ผˆ IgE๏ผ‰ in human whole blood, serum or plasma.The test is used as an aid detection of allergic diseases

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing